Jump to content

News Forum - Clinical trials kick off for Pfizer-BioNTech’s new Omicron-targeting vaccine


Thaiger
 Share

Recommended Posts

Trials have got underway on a new Pfizer-BioNTech vaccine that targets the Omicron Covid-19 variant. According to a Reuters report, the trials will examine the level of immune response generated against the highly-contagious strain. It’s understood researchers will test the vaccine as a 3-dose regimen in unvaccinated participants and as a booster in those who’ve had 2 doses of the original Pfizer vaccine. The trial will also compare the results of giving a fourth dose of the current vaccine to people who’ve received a third dose of it 3 – 6 months earlier, compared to giving them a fourth dose […]

The story Clinical trials kick off for Pfizer-BioNTech’s new Omicron-targeting vaccine as seen on Thaiger News.

Read the full story

Link to comment
Share on other sites

Guest
This topic is now closed to further replies.
 Share

×
×
  • Create New...

Important Information

By posting on Thaiger Talk you agree to the Terms of Use